Author
Listed:
- Kea M. Jones
(Department of Obstetrics and Gynecology, Meharry Medical College, Nashville, TN 37208-3599, USA)
- Mohammad S. Niaz
(Department of Obstetrics and Gynecology, Meharry Medical College, Nashville, TN 37208-3599, USA)
- Cynthia M. Brooks
(Department of Obstetrics and Gynecology, Meharry Medical College, Nashville, TN 37208-3599, USA)
- Shannon I. Roberson
(Department of Obstetrics and Gynecology, Meharry Medical College, Nashville, TN 37208-3599, USA)
- Maria P. Aguinaga
(Department of Obstetrics and Gynecology, Meharry Medical College, Nashville, TN 37208-3599, USA
Sickle Cell Center, Meharry Medical College, Nashville, TN 37208-3599, USA)
- Edward R. Hills
(Department of Obstetrics and Gynecology, Meharry Medical College, Nashville, TN 37208-3599, USA)
- Valerie Montgomery Rice
(Department of Obstetrics and Gynecology, Meharry Medical College, Nashville, TN 37208-3599, USA)
- Phillip Bourne
(Department of Obstetrics and Gynecology, Meharry Medical College, Nashville, TN 37208-3599, USA)
- Donald Bruce
(Department of Obstetrics and Gynecology, Meharry Medical College, Nashville, TN 37208-3599, USA)
- Anthony E. Archibong
(Department of Obstetrics and Gynecology, Meharry Medical College, Nashville, TN 37208-3599, USA)
Abstract
Two experiments were conducted to determine: 1) whether the adult male transgenic sickle cell mouse (Tg58 × Tg98; TSCM), exhibits the patterns of reproductive endpoints (hypogonadism) characteristic of men with sickle cell disease (SCD) and 2) whether hydroxyurea (HU) exacerbates this condition. In Experiment 1, blood samples were collected from adult age-matched TSCM and ICR mice (ICRM) (N = 10/group) for plasma testosterone measurements. Subsequently, mice were sacrificed, testes excised and weighed and stored spermatozoa recovered for the determination of sperm density, progressive motility and percentage of spermatozoa with normal morphology. In experiment 2, adult male TSCM were orally treated with 25 mg HU/kg body weight/day for 28 or 56 days. Control mice received the vehicle for HU (saline) as described above. At the end of the treatment periods, blood samples were collected for quantification of circulating testosterone. Subsequently, mice were sacrificed, testes and epididymides were recovered and weighed and one testis per mouse was subjected to histopathology. Stored spermatozoa were recovered for the determination of indices of sperm quality mentioned in Experiment 1. Testis weight, stored sperm density, progressive motility, percentage of spermatozoa with normal morphology and plasma testosterone concentrations of TSCM were significantly lower by 40, 65, 40, 69 and 66%, respectively than those of ICRM. These data indicate that adult TSCM used in this study suffered from hypogonadism, characteristically observed among adult male SCD patients. In Experiment 2, HU treatment significantly decreased testis weight on day 28, (0.09 ± 0.004g) that was further decreased on day 56 (0.06 ± 0.003g; treatment x time interaction) compared with controls (day 28, 0.15 ± 0.01g; day 56, 2, 0.16 ± 0.01g). Concomitant with a 52% shrinkage (P
Suggested Citation
Kea M. Jones & Mohammad S. Niaz & Cynthia M. Brooks & Shannon I. Roberson & Maria P. Aguinaga & Edward R. Hills & Valerie Montgomery Rice & Phillip Bourne & Donald Bruce & Anthony E. Archibong, 2009.
"Adverse Effects of a Clinically Relevant Dose of Hydroxyurea Used for the Treatment of Sickle Cell Disease on Male Fertility Endpoints,"
IJERPH, MDPI, vol. 6(3), pages 1-21, March.
Handle:
RePEc:gam:jijerp:v:6:y:2009:i:3:p:1124-1144:d:4278
Download full text from publisher
Most related items
These are the items that most often cite the same works as this one and are cited by the same works as this one.
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:gam:jijerp:v:6:y:2009:i:3:p:1124-1144:d:4278. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: MDPI Indexing Manager (email available below). General contact details of provider: https://www.mdpi.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.